Skip to main content

Advertisement

Log in

Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Vitamin C deficiency is common in chronic kidney disease (CKD) due to losses through dialysis and dietary intake below requirement. We investigated prevalence of vitamin C deficiency and impact of vitamin C treatment in deficient/insufficient patients.

Methods

A prospective cohort study in patients aged 1–18 years with CKD stages 4 and 5D collected demographic data including underlying disease, treatment, and anthropometric assessment. Vitamin C intake was assessed using 24-h dietary recall. Hemoglobin, iron status, serum vitamin C, and serum oxalate were measured at baseline and after treatment. Vitamin C (250 mg/day) was given orally for 3 months to deficient/insufficient patients.

Results

Nineteen patients (mean age 12.00 ± 4.1 years) showed prevalence of 10.6% vitamin C insufficiency and 78.9% deficiency. There were no associations between vitamin C level and daily vitamin C intake (p = 0.64) or nutritional status (p = 0.87). Median serum vitamin C was 1.51 (0.30–1.90) mg/L. In 16 patients receiving treatment, median serum vitamin C increased from 1.30 (0.23–1.78) to 3.22 (1.77–5.96) mg/L (p = 0.008) without increasing serum oxalate (79.92 (56.6–106.84) vs. 80.47 (56.88–102.95) μmol/L, p = 0.82). However, 62.5% failed to achieve normal vitamin C levels. Ordinal regression analysis revealed patients with non-oligoanuric CKD were less likely to achieve normal vitamin C levels (β = − 3.41, p = 0.03).

Conclusion

We describe high prevalence of vitamin C insufficiency/deficiency among pediatric CKD patients. Vitamin C levels could not be solely predicted by nutritional status or daily intake. The treatment regimen raised serum vitamin C without increasing serum oxalate; however, it was largely insufficient to normalize levels, particularly in non-oligoanuric CKD.

.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P (2008) High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton) 13:17–22

    CAS  Google Scholar 

  2. Sirover WD, Liu Y, Logan A, Hunter K, Benz RL, Prasad D, Avila J, Venkatchalam T, Weisberg LS, Handelman GJ (2015) Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis. J Ren Nutr 25:292–300

    CAS  PubMed  Google Scholar 

  3. Norman LJ, Coleman JE, Macdonald IA, Tomsett AM, Watson AR (2000) Nutrition and growth in relation to severity of renal disease in children. Pediatr Nephrol 15:259–265

    CAS  PubMed  Google Scholar 

  4. Kriley M, Warady BA (1991) Vitamin status of pediatric patients receiving long-term peritoneal dialysis. Am J Clin Nutr 53:1476–1479

    CAS  PubMed  Google Scholar 

  5. Deicher R, Horl WH (2003) Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press Res 26:100–106

    CAS  PubMed  Google Scholar 

  6. Mydlik M, Derzsiova K, Zemberova E (1999) Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin B(6), oxalic acid and vitamin C in chronic renal failure. Miner Electrolyte Metab 25:352–356

    CAS  PubMed  Google Scholar 

  7. Raimann JG, Levin NW, Craig RG, Sirover W, Kotanko P, Handelman G (2013) Is vitamin C intake too low in dialysis patients? Semin Dial 26:1–5

    PubMed  Google Scholar 

  8. Pinnell SR (1985) Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J Biol Med 58:553–559

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Wapnick AA, Bothwell TH, Seftel H (1970) The relationship between serum ion levels and ascorbic acid stores in siderotic Bantu. Br J Haematol 19:271–276

    CAS  PubMed  Google Scholar 

  10. Fidler MC, Davidsson L, Zeder C, Walczyk T, Hurrell RF (2003) Iron absorption from ferrous fumarate in adult women is influenced by ascorbic acid but not by Na2EDTA. Br J Nutr 90:1081–1085

    CAS  PubMed  Google Scholar 

  11. Unruh M, Benz R, Greene T, Yan G, Beddhu S, De Vita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB, HEMO Study Group (2004) Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO study. Kidney Int 66:355–366

    PubMed  Google Scholar 

  12. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 93:3704–3709

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Kocyigit I, Yucel HE, Cakmak O, Dogruel F, Durukan DB, Korkar H, Unal A, Sipahioglu MH, Oymak O, Gurgan CA, Tokgoz B (2014) An ignored cause of inflammation in patients undergoing continuous ambulatory peritoneal dialysis: periodontal problems. Int Urol Nephrol 46:2021–2028

    PubMed  Google Scholar 

  14. Iwasaki M, Manz MC, Taylor GW, Yoshihara A, Miyazaki H (2012) Relations of serum ascorbic acid and alpha-tocopherol to periodontal disease. J Dent Res 91:167–172

    CAS  PubMed  Google Scholar 

  15. Davison SN (2003) Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis 42:1239–1247

    PubMed  Google Scholar 

  16. Fain O (2005) Musculoskeletal manifestations of scurvy. Joint Bone Spine 72:124–128

    PubMed  Google Scholar 

  17. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ (2007) Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 3:138–153

    CAS  PubMed  Google Scholar 

  18. Kittisakmontri K, Swangtrakul N, Padungmaneesub W, Charoenkwan P (2016) Gingival bleeding and bloody dialysate: a case report of scurvy in a child with end-stage renal disease receiving peritoneal dialysis. J Ren Nutr 26:407–411

    PubMed  Google Scholar 

  19. KDOQI Work Group (2009) KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Executive summary. Am J Kidney Dis 53:S11–S104

    Google Scholar 

  20. The Thai Food and Drug Administration (2003) Dietary reference intakes for Thai people. Panicha Poojin, Nonthaburi, Thailand. http://www.fda.moph.go.th/sites/food/Permission/4.4.8-DRI.pdf Accessed 20 June 2017

  21. Dallman PR (1977) Blood and blood-forming tissue. In: A. R (ed) Pediatrics. Appleton-Century-Crofts, Norwalk, p 111

  22. Reuler JB, Broudy VC, Cooney TG (1985) Adult scurvy. JAMA 253:805–807

    CAS  PubMed  Google Scholar 

  23. American Academy of Pediatrics Committee on Nutrition (2013) Water-soluble vitamins. In: Kleinman RE, Greer FR (eds) Pediatric nutrition. American Academy of Pediatrics, IL, pp 526–527

    Google Scholar 

  24. Weinstein M, Babyn P, Zlotkin S (2001) An orange a day keeps the doctor away: scurvy in the year 2000. Pediatrics 108:E55

    CAS  PubMed  Google Scholar 

  25. Zhang K, Dong J, Cheng X, Bai W, Guo W, Wu L, Zuo L (2012) Association between vitamin C deficiency and dialysis modalities. Nephrology (Carlton) 17:452–457

    CAS  Google Scholar 

  26. Bossola M, Di Stasio E, Viola A, Leo A, Carlomagno G, Monteburini T, Cenerelli S, Santarelli S, Boggi R, Miggiano G, Vulpio C, Mele C, Tazza L (2014) Dietary intake of trace elements, minerals, and vitamins of patients on chronic hemodialysis. Int Urol Nephrol 46:809–815

    CAS  PubMed  Google Scholar 

  27. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, Li PK, Woo J (2002) Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 76:569–576

    CAS  PubMed  Google Scholar 

  28. Pereira AM, Hamani N, Nogueira PC, Carvalhaes JT (2000) Oral vitamin intake in children receiving long-term dialysis. J Ren Nutr 10:24–29

    CAS  PubMed  Google Scholar 

  29. Warady BA, Kriley M, Alon U, Hellerstein S (1994) Vitamin status of infants receiving long-term peritoneal dialysis. Pediatr Nephrol 8:354–356

    CAS  PubMed  Google Scholar 

  30. Lim SL, Lee EJ, Myint CC, Ong KT, Tay ME, Yusuf N, Ong CN (2001) Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 17:215–218

    CAS  PubMed  Google Scholar 

  31. Hultqvist M, Hegbrant J, Nilsson-Thorell C, Lindholm T, Nilsson P, Linden T, Hultqvist-Bengtsson U (1997) Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol 47:37–46

    CAS  PubMed  Google Scholar 

  32. Hahn T, Adams W, Williams K (2019) Is vitamin C enough? A case report of scurvy in a five-year-old girl and review of the literature. BMC Pediatr 19:74

    PubMed  PubMed Central  Google Scholar 

  33. Ceglie G, Macchiarulo G, Marchili MR, Marchesi A, Rotondi Aufiero L, Di Camillo C, Villani A (2019) Scurvy: still a threat in the well-fed first world? Arch Dis Child 104:381–383

    PubMed  Google Scholar 

  34. Ratanachu-Ek S, Sukswai P, Jeerathanyasakun Y, Wongtapradit L (2003) Scurvy in pediatric patients: a review of 28 cases. J Med Assoc Thail 86(Suppl 3):S734–S740

    Google Scholar 

  35. Chan D, Irish A, Dogra G (2005) Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients. Nephrology (Carlton) 10:336–340

    CAS  Google Scholar 

  36. Descombes E, Hanck AB, Fellay G (1993) Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 43:1319–1328

    CAS  PubMed  Google Scholar 

  37. Boudouris G, Verginadis II, Simos YV, Zouridakis A, Ragos V, Karkabounas S, Evangelou AM (2013) Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation. Int Urol Nephrol 45:1137–1144

    CAS  PubMed  Google Scholar 

  38. Sirover WD, Siddiqui AA, Benz RL (2008) Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study. Ren Fail 30:884–889

    CAS  PubMed  Google Scholar 

  39. Tomson CR, Channon SM, Parkinson IS, McArdle P, Qureshi M, Ward MK, Laker MF (1989) Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility. Clin Chim Acta 180:255–264

    CAS  PubMed  Google Scholar 

  40. Canavese C, Petrarulo M, Massarenti P, Berutti S, Fenoglio R, Pauletto D, Lanfranco G, Bergamo D, Sandri L, Marangella M (2005) Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 45:540–549

    CAS  PubMed  Google Scholar 

  41. Tomson CR, Channon SM, Parkinson IS, Morley AR, Lennard TW, Parrott NR, Laker MF (1988) Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure. J Clin Pathol 41:1107–1113

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Barratt TM, Kasidas GP, Murdoch I, Rose GA (1991) Urinary oxalate and glycolate excretion and plasma oxalate concentration. Arch Dis Child 66:501–503

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Hoppe B, Kemper MJ, Hvizd MG, Sailer DE, Langman CB (1998) Simultaneous determination of oxalate, citrate and sulfate in children’s plasma with ion chromatography. Kidney Int 53:1348–1352

    CAS  PubMed  Google Scholar 

  44. Porowski T, Zoch-Zwierz W, Konstantynowicz J, Korzeniecka-Kozerska A, Michaluk-Skutnik J, Porowska H (2008) Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol 23:1787–1794

    PubMed  Google Scholar 

  45. Yamauchi A, Fujii M, Shirai D, Mikami H, Okada A, Imai E, Ando A, Orita Y, Kamada T (1986) Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 25:181–185

    CAS  PubMed  Google Scholar 

  46. Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR (1988) Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine. Nephrol Dial Transplant 3:28–32

    CAS  PubMed  Google Scholar 

  47. Costello JF, Sadovnic MJ, Cottington EM (1991) Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal. J Am Soc Nephrol 1:1289–1298

    CAS  PubMed  Google Scholar 

  48. Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC (1999) Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 55:2477–2486

    CAS  PubMed  Google Scholar 

  49. Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F (2000) Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. J Nephrol 13:444–449

    CAS  PubMed  Google Scholar 

  50. Sultana T, DeVita MV, Michelis MF (2016) Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency. Int Urol Nephrol 48:1519–1524

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Ms. Sukthiporn Eamchanprateep the Medical Technologist for her kind assistance with serum oxalate analysis and Ms. Purisa Wecharak the Nutritionist for dietary assessment.

Funding

The present study was supported by the Faculty of Medicine Research Fund, grant no. 029-2560, Chiang Mai University, Chiang Mai, Thailand. The funding sources had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wattana Chartapisak.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 59 kb)

ESM 2

(PPTX 85 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hongsawong, N., Chawprang, N., Kittisakmontri, K. et al. Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease. Pediatr Nephrol 36, 397–408 (2021). https://doi.org/10.1007/s00467-020-04662-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-020-04662-9

Keywords

Navigation